Inhibitory Antibodies
-
F1935 Anti-CD3 & EpCAM Antibody (Catumaxomab (Catumaxomab (huIgG1-rat IgG2b))Summary: Anti-CD3 & EpCAM Antibody (Catumaxomab (Catumaxomab (huIgG1-rat IgG2b)) -
F1936 Anti-CD3 & EpCAM Antibody (Catumaxomab (Catumaxomab (mIgG2a-rat IgG2b))Summary: Anti-CD3 & EpCAM Antibody (Catumaxomab (Catumaxomab (mIgG2a-rat IgG2b)) -
F1937 Anti-CD36 Antibody (Ona Thera Patent Anti-Cd36)Summary: Anti-CD36 Antibody (Ona Thera Patent Anti-Cd36) -
F1938 Anti-CD48 Antibody (Regeneron patent anti-CD48)Summary: Anti-CD48 Antibody (Regeneron patent anti-CD48) -
F1939 Anti-CD5 Antibody (Magenta patent anti-CD5)Summary: Anti-CD5 Antibody (Magenta patent anti-CD5) -
F1940 Anti-CD59 Antibody (Mellitus patent anti-CD59)Summary: Anti-CD59 Antibody (Mellitus patent anti-CD59) -
F1941 Anti-CD69 Antibody (Genefrontier patent anti-CD69)Summary: Anti-CD69 Antibody (Genefrontier patent anti-CD69) -
F1942 Anti-CD7 Antibody (Persongen patent anti-CD7)Summary: Anti-CD7 Antibody (Persongen patent anti-CD7) -
F1943 Anti-CDCP1/CD318 Antibody (U.California patent anti-CDCP1)Summary: Anti-CDCP1/CD318 Antibody (U.California patent anti-CDCP1) -
F1944 Anti-CEACAM1/CD66a Antibody (Chaim Sheba Med. Cntr. patent anti-CEACAM1)Summary: Anti-CEACAM1/CD66a Antibody (Chaim Sheba Med. Cntr. patent anti-CEACAM1)